Lingqiang Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lingqiang Zhang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Haining Fan
Qinghai University Affiliated Hospital
1 shared publication - Jingxin Yan
Department of Radiology, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, China
1 shared publication - Li Ren
Qinghai University Affiliated Hospital, Qinghai, Xining, China
1 shared publication - Manjun Deng
Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, Qinghai, China
1 shared publication - Zheheng Zhang
Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, People’s Republic of China
1 shared publication - Zhixin Wang
Affiliated Hospital of Qinghai University
1 shared publication
Latest Publications
- 5 March 2022
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 15 (3) , 513-521
Greater than or equal to 8 mm is a safe diameter of common bile duct for primary duct closure: single-arm meta-analysis and systematic review
Greater than or equal to 8 mm was often used as the safe diameter of primary duct closure (PDC) after laparoscopic common bile duct exploration (LCBDE) in previous studies, but it is impossible to verify the source of this safe diameter, and lack of evidence for the safe diameter of PDC. Hence, this study evaluates the incidence of postoperative complications by single-arm meta-analysis to demonstrate the feasibility of using 8 mm as the safe diameter of PDC, so as to provide reference for clinical selection. Eligible studies were searched by MEDLINE, the Cochrane Library, Embase, and Web of Science from January 1995 to May 2021, investigating eligible literature using PDC after LCBDE for methods of common bile duct closure. The single-arm meta-analysis was analyzed by “meta” package under R 4.0.5, and the pooled incidence of postoperative complications was calculated. Twelve literatures were enrolled in this single-arm meta-analysis including 792 patients. The pooled complications rate including total complications (13.1%, 95% CI 10.1–15.6%), total biliary duct-related complications (9.4%, 95% CI 7.4–11.6%), residual stones (1.3%, 95% CI 0.3–2.7%), bile leakage (5.1%, 95% CI 3.5–6.9%), postoperative pneumonia (2.1%, 95% CI 0.8–3.8%), postoperative acute pancreatitis (1.8%, 95% CI 0.2–4.3%), and stone recurrence (2.6%, 95% CI 1.1–4.4%). The clinical indication of PDC after LCBDE should follow that the diameter of common bile duct ≥ 8 mm as the safe diameter.
- 5 March 2022
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 15 (3) , 513-521
Greater than or equal to 8 mm is a safe diameter of common bile duct for primary duct closure: single-arm meta-analysis and systematic review
Greater than or equal to 8 mm was often used as the safe diameter of primary duct closure (PDC) after laparoscopic common bile duct exploration (LCBDE) in previous studies, but it is impossible to verify the source of this safe diameter, and lack of evidence for the safe diameter of PDC. Hence, this study evaluates the incidence of postoperative complications by single-arm meta-analysis to demonstrate the feasibility of using 8 mm as the safe diameter of PDC, so as to provide reference for clinical selection. Eligible studies were searched by MEDLINE, the Cochrane Library, Embase, and Web of Science from January 1995 to May 2021, investigating eligible literature using PDC after LCBDE for methods of common bile duct closure. The single-arm meta-analysis was analyzed by “meta” package under R 4.0.5, and the pooled incidence of postoperative complications was calculated. Twelve literatures were enrolled in this single-arm meta-analysis including 792 patients. The pooled complications rate including total complications (13.1%, 95% CI 10.1–15.6%), total biliary duct-related complications (9.4%, 95% CI 7.4–11.6%), residual stones (1.3%, 95% CI 0.3–2.7%), bile leakage (5.1%, 95% CI 3.5–6.9%), postoperative pneumonia (2.1%, 95% CI 0.8–3.8%), postoperative acute pancreatitis (1.8%, 95% CI 0.2–4.3%), and stone recurrence (2.6%, 95% CI 1.1–4.4%). The clinical indication of PDC after LCBDE should follow that the diameter of common bile duct ≥ 8 mm as the safe diameter.